Long‐term outcomes and cost effectiveness of high‐dose dexamethasone for cardiac surgery: a randomised trial
- 20 March 2017
- journal article
- research article
- Published by Wiley in Anaesthesia
- Vol. 72 (6), 704-713
- https://doi.org/10.1111/anae.13853
Abstract
Prophylactic intra-operative administration of dexamethasone may improve short-term clinical outcomes in cardiac surgical patients. The purpose of this study was to evaluate long-term clinical outcomes and cost effectiveness of dexamethasone versus placebo. Patients included in the multicentre, randomised, double-blind, placebo-controlled DExamethasone for Cardiac Surgery (DECS) trial were followed up for 12 months after their cardiac surgical procedure. In the DECS trial, patients received a single intra-operative dose of dexamethasone 1 mg.kg−1 (n = 2239) or placebo (n = 2255). The effects on the incidence of major postoperative events were evaluated. Also, overall costs for the 12-month postoperative period, and cost effectiveness, were compared between groups. Of 4494 randomised patients, 4457 patients (99%) were followed up until 12 months after surgery. There was no difference in the incidence of major postoperative events, the relative risk (95%CI) being 0.86 (0.72-1.03); p = 0.1. Treatment with dexamethasone reduced costs per patient by £921 [€1084] (95%CI £−1672 to −137; p = 0.02), mainly through reduction of postoperative respiratory failure and duration of postoperative hospital stay. The probability of dexamethasone being cost effective compared with placebo was 97% at a threshold value of £17,000 [€20,000] per quality-adjusted life year. We conclude that intra-operative high-dose dexamethasone did not have an effect on major adverse events at 12 months after cardiac surgery, but was associated with a reduction in costs. Routine dexamethasone administration is expected to be cost effective at commonly accepted threshold levels for cost effectiveness.Funding Information
- ZonMw
- Hartstichting (2007B125)
This publication has 19 references indexed in Scilit:
- The Prevention and Treatment of Missing Data in Clinical TrialsThe New England Journal of Medicine, 2012
- Dealing With Missing Outcome Data in Randomized Trials and Observational StudiesAmerican Journal of Epidemiology, 2011
- Acute Kidney Injury: A Relevant Complication After Cardiac SurgeryThe Annals of Thoracic Surgery, 2011
- Heart Disease and Stroke Statistics—2011 UpdateCirculation, 2011
- Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trialsEuropean Heart Journal, 2008
- Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial InfarctionEuropean Heart Journal, 2007
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1988